Figure 4From: Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder Estimated change in weight in olanzapine-treated black and white patients over 24 weeks. Graph based on MMRM Model including fixed terms baseline weight, treatment week, protocol, investigator, race, and ethnic origin × treatment week. Race P-value = 0.13.Back to article page